Invicta Diagnos.
NSE: INVICTA · Healthcare Service Provider
Limited coverage
We are not actively covering this company or have limited coverage today. Click to request coverage.
Snapshot
Unlock Invicta Diagnos.'s vital signs
Growth · Profitability · Valuation · Strength · Conviction
Company Overview
Business
Invicta Diagnostic Limited is a healthcare service provider specialising in radiology and pathology solutions. The company operates a diagnostic chain within the Mumbai Metropolitan Region.
Business Model
The company operates on a hub-and-spoke model, leveraging a centralised laboratory supported by seven diagnostic centres to deliver diagnostic services.
- Diagnostic Centres:7
- Centralised Laboratories:1
Growth Outlook
Growth is expected to be driven by the expansion of its diagnostic network and the optimisation of its hub-and-spoke operational model within the Mumbai Metropolitan Region.
Key Risks
- Geographic Concentration. The company's operations are heavily concentrated in the Mumbai Metropolitan Region, exposing it to localised economic and regulatory risks.
- Intense Competition. The diagnostic services sector in India is highly fragmented and competitive, which may exert pressure on pricing and margins.
- Regulatory Compliance. Healthcare providers are subject to stringent quality standards and evolving government regulations regarding medical testing and diagnostic facilities.
Start your research today
Unlock AI insights, financials, peers and live data on Invicta Diagnos. and 5,000+ companies — free.
Peers · Healthcare Service Provider
| Company | Mkt Cap | P/E | EV/EBITDA | Rev Gr YoY | EBITDA Mgn | ROE | ROCE | 1Y Return |
|---|---|---|---|---|---|---|---|---|
Invicta Diagnos.INVICTA | ₹87 Cr | — | — | — | 30.2% | — | — | — |
Suraksha Diagnostic Ltd.SURAKSHA | ₹1,851 Cr | 50.02 | 17.47 | 22.5% | 32.7% | 15.8% | 18.6% | +17.7% |
Krsnaa Diagnostics Ltd.KRSNAA | ₹1,817 Cr | 18.46 | 8.75 | 10.2% | 32.5% | 10.5% | 13.3% | -28.2% |
3B BlackBio Dx Ltd3BBLACKBIO | ₹1,229 Cr | 25.08 | 14.76 | 54.3% | 52.8% | 19.0% | 24.1% | +18.1% |
One Global Service Provider LimitedONEGLOBAL | ₹1,062 Cr | 13.88 | 10.52 | 161.6% | 19.4% | 69.4% | 92.5% | +93.2% |
Gaudium IVF and Women Health LimitedGAUDIUMIVF | ₹857 Cr | — | — | — | 36.0% | — | — | — |
As of Mar 2026
Financials
Invicta Diagnos.
NSE: INVICTA · Healthcare Service Provider
Limited coverage
We are not actively covering this company or have limited coverage today. Click to request coverage.
Snapshot
Unlock Invicta Diagnos.'s vital signs
Growth · Profitability · Valuation · Strength · Conviction
Company Overview
Business
Invicta Diagnostic Limited is a healthcare service provider specialising in radiology and pathology solutions. The company operates a diagnostic chain within the Mumbai Metropolitan Region.
Business Model
The company operates on a hub-and-spoke model, leveraging a centralised laboratory supported by seven diagnostic centres to deliver diagnostic services.
- Diagnostic Centres:7
- Centralised Laboratories:1
Growth Outlook
Growth is expected to be driven by the expansion of its diagnostic network and the optimisation of its hub-and-spoke operational model within the Mumbai Metropolitan Region.
Key Risks
- Geographic Concentration. The company's operations are heavily concentrated in the Mumbai Metropolitan Region, exposing it to localised economic and regulatory risks.
- Intense Competition. The diagnostic services sector in India is highly fragmented and competitive, which may exert pressure on pricing and margins.
- Regulatory Compliance. Healthcare providers are subject to stringent quality standards and evolving government regulations regarding medical testing and diagnostic facilities.
Start your research today
Unlock AI insights, financials, peers and live data on Invicta Diagnos. and 5,000+ companies — free.
Peers · Healthcare Service Provider
As of Mar 2026